Transforming Allogeneic Cell Therapy for Blood, Genetic and Immune Diseases

We are dedicated to developing high-precision allogeneic cell therapies designed to safely replace patients’ diseased blood and immune system with a healthy one.

Orca Bio announces its Series D financing round. Click here to learn more.

Bitnami